Αποτελέσματα Αναζήτησης
Cannabis remains by far the most commonly consumed illicit drug in Europe. On this page, you can find the latest analysis of the drug situation for cannabis in Europe, including prevalence of use, treatment demand, seizures, price and purity, harms and more.
6 Ιαν 2012 · This study brings together available evidence to provide a comprehensive analysis of cannabis production and markets across the EU.
Yet, for new ideas to emerge about how the EU could take a common position, it is important for the EU to encourage the debate about what has worked, and what has not, among drug policies. This should include cannabis policy innovations currently being implemented within the boundaries of the EU.
‘EU Drug Market: Cannabis’ describes the European cannabis market from production and trafficking, to distribution and use. It details the processes, materials and players involved at different stages and levels of the market.
Introduction. Under international laws, cultivation, supply and possession of cannabis should be allowed only for ‘medical and scientific purposes’. In general, possession of the drug for personal use should be a crime, to deter use, and most countries make this punishable by imprisonment.
20 Μαρ 2024 · In Europe, expected regulatory reforms and growing acceptance of both medical and recreational cannabis use are contributing to a robust growth in the cannabis sector. The European market is becoming increasingly sophisticated, with a regulatory focus on consistency and compliance.
23 Σεπ 2021 · Between 2010 and 2019, past-month prevalence of cannabis use increased by 27% in European adults (from 3·1 to 3·9%), with most pronounced relative increases observed among 35-64 year-olds. In 13 out of 26 countries, over 20% of all past-month users reported high-risk use patterns.
